CN106483298A - 用于检测细胞角蛋白19 片段的化学发光免疫试剂盒 - Google Patents
用于检测细胞角蛋白19 片段的化学发光免疫试剂盒 Download PDFInfo
- Publication number
- CN106483298A CN106483298A CN201610863945.5A CN201610863945A CN106483298A CN 106483298 A CN106483298 A CN 106483298A CN 201610863945 A CN201610863945 A CN 201610863945A CN 106483298 A CN106483298 A CN 106483298A
- Authority
- CN
- China
- Prior art keywords
- cyfra21
- pbs
- solution
- value
- quantitative determination
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108010036226 antigen CYFRA21.1 Proteins 0.000 title claims abstract description 49
- 239000012634 fragment Substances 0.000 title claims abstract description 8
- 238000003018 immunoassay Methods 0.000 title abstract description 3
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 29
- 239000000126 substance Substances 0.000 claims abstract description 25
- 239000000758 substrate Substances 0.000 claims abstract description 20
- 238000002372 labelling Methods 0.000 claims abstract description 18
- 239000000203 mixture Substances 0.000 claims abstract description 14
- 238000002360 preparation method Methods 0.000 claims abstract description 14
- 102000004190 Enzymes Human genes 0.000 claims abstract description 13
- 108090000790 Enzymes Proteins 0.000 claims abstract description 13
- 238000004140 cleaning Methods 0.000 claims abstract description 11
- 102100033420 Keratin, type I cytoskeletal 19 Human genes 0.000 claims abstract description 7
- 108010066302 Keratin-19 Proteins 0.000 claims abstract description 7
- 239000000243 solution Substances 0.000 claims description 29
- 239000004005 microsphere Substances 0.000 claims description 21
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 8
- 229920000604 Polyethylene Glycol 200 Polymers 0.000 claims description 8
- 239000000872 buffer Substances 0.000 claims description 8
- 235000010445 lecithin Nutrition 0.000 claims description 8
- 239000000787 lecithin Substances 0.000 claims description 8
- 229940067606 lecithin Drugs 0.000 claims description 8
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 7
- 108010001336 Horseradish Peroxidase Proteins 0.000 claims description 6
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 6
- 238000006243 chemical reaction Methods 0.000 claims description 6
- 230000008878 coupling Effects 0.000 claims description 6
- 238000010168 coupling process Methods 0.000 claims description 6
- 238000005859 coupling reaction Methods 0.000 claims description 6
- 238000002955 isolation Methods 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 5
- 239000012467 final product Substances 0.000 claims description 4
- 239000000047 product Substances 0.000 claims description 4
- 239000012086 standard solution Substances 0.000 claims description 4
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 claims description 3
- 229920001213 Polysorbate 20 Polymers 0.000 claims description 3
- 238000007796 conventional method Methods 0.000 claims description 3
- 238000000502 dialysis Methods 0.000 claims description 3
- HWYHZTIRURJOHG-UHFFFAOYSA-N luminol Chemical compound O=C1NNC(=O)C2=C1C(N)=CC=C2 HWYHZTIRURJOHG-UHFFFAOYSA-N 0.000 claims description 3
- 239000008363 phosphate buffer Substances 0.000 claims description 3
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims description 3
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims description 3
- 238000000746 purification Methods 0.000 claims description 3
- 230000008859 change Effects 0.000 claims description 2
- 238000009792 diffusion process Methods 0.000 claims description 2
- 230000003139 buffering effect Effects 0.000 claims 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims 1
- JBPBWEKERUNUQY-UHFFFAOYSA-N C(CCCCCCCCCCCCCCCCC)Cl(C)(C)C Chemical compound C(CCCCCCCCCCCCCCCCC)Cl(C)(C)C JBPBWEKERUNUQY-UHFFFAOYSA-N 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 238000012360 testing method Methods 0.000 abstract description 10
- 238000001514 detection method Methods 0.000 abstract description 8
- 238000013467 fragmentation Methods 0.000 abstract 1
- 238000006062 fragmentation reaction Methods 0.000 abstract 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 238000003127 radioimmunoassay Methods 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 3
- 102000011782 Keratins Human genes 0.000 description 2
- 108010076876 Keratins Proteins 0.000 description 2
- 239000007979 citrate buffer Substances 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- 239000011806 microball Substances 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 206010005003 Bladder cancer Diseases 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 206010033128 Ovarian cancer Diseases 0.000 description 1
- 206010061535 Ovarian neoplasm Diseases 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 208000037842 advanced-stage tumor Diseases 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 201000008275 breast carcinoma Diseases 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000012830 cancer therapeutic Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 230000001427 coherent effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000003748 differential diagnosis Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000006148 magnetic separator Substances 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 201000005112 urinary bladder cancer Diseases 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
- G01N21/76—Chemiluminescence; Bioluminescence
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
- G01N33/54326—Magnetic particles
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies; monoclonal antibodies per se are classified with their corresponding antigens
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Plasma & Fusion (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Abstract
Description
N=5 | 组1 | 组2 | 组3 | 组4 |
5天 | 99.1% | 82.4% | 91.6% | 89.3% |
15天 | 98.8% | 72.7% | 83.3% | 78.2% |
30天 | 98.2% | 64.1% | 71.9% | 68.7% |
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610863945.5A CN106483298B (zh) | 2016-09-29 | 2016-09-29 | 用于检测细胞角蛋白19片段的化学发光免疫试剂盒 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610863945.5A CN106483298B (zh) | 2016-09-29 | 2016-09-29 | 用于检测细胞角蛋白19片段的化学发光免疫试剂盒 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106483298A true CN106483298A (zh) | 2017-03-08 |
CN106483298B CN106483298B (zh) | 2017-08-11 |
Family
ID=58269007
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610863945.5A Active CN106483298B (zh) | 2016-09-29 | 2016-09-29 | 用于检测细胞角蛋白19片段的化学发光免疫试剂盒 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106483298B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107462721A (zh) * | 2017-07-10 | 2017-12-12 | 江苏福隆生物技术有限公司 | 细胞角蛋白19片段的板式化学发光法检测试剂盒及制备方法 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101228442A (zh) * | 2005-07-20 | 2008-07-23 | 协和梅迪克斯株式会社 | 生物样品中肽的稳定方法 |
CN101377501A (zh) * | 2007-08-31 | 2009-03-04 | 北京科美东雅生物技术有限公司 | 细胞角蛋白19片段化学发光免疫分析测定试剂盒及其制备方法 |
CN101533011A (zh) * | 2009-04-10 | 2009-09-16 | 北京倍爱康生物技术有限公司 | 一种日本血吸虫虫卵抗体磁微粒分离酶联免疫检测方法 |
CN101949943A (zh) * | 2010-08-03 | 2011-01-19 | 郑州安图绿科生物工程有限公司 | 促甲状腺激素定量检测试剂盒及其制备方法 |
CN102426245A (zh) * | 2011-08-31 | 2012-04-25 | 内蒙古科慧生物科技有限责任公司 | 细胞角质蛋白19片段(cyfra21-1)定量测定试剂盒及其检测方法 |
CN103698520A (zh) * | 2013-11-28 | 2014-04-02 | 广州甘蔗糖业研究所 | 单克隆抗体免疫比浊定量检测α-葡聚糖的试剂盒 |
JP2016105066A (ja) * | 2014-12-01 | 2016-06-09 | 三洋化成工業株式会社 | 磁性シリカ粒子、該磁性シリカ粒子を用いた測定対象物質測定方法及び測定対象物質測定用試薬 |
-
2016
- 2016-09-29 CN CN201610863945.5A patent/CN106483298B/zh active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101228442A (zh) * | 2005-07-20 | 2008-07-23 | 协和梅迪克斯株式会社 | 生物样品中肽的稳定方法 |
CN101377501A (zh) * | 2007-08-31 | 2009-03-04 | 北京科美东雅生物技术有限公司 | 细胞角蛋白19片段化学发光免疫分析测定试剂盒及其制备方法 |
CN101533011A (zh) * | 2009-04-10 | 2009-09-16 | 北京倍爱康生物技术有限公司 | 一种日本血吸虫虫卵抗体磁微粒分离酶联免疫检测方法 |
CN101949943A (zh) * | 2010-08-03 | 2011-01-19 | 郑州安图绿科生物工程有限公司 | 促甲状腺激素定量检测试剂盒及其制备方法 |
CN102426245A (zh) * | 2011-08-31 | 2012-04-25 | 内蒙古科慧生物科技有限责任公司 | 细胞角质蛋白19片段(cyfra21-1)定量测定试剂盒及其检测方法 |
CN103698520A (zh) * | 2013-11-28 | 2014-04-02 | 广州甘蔗糖业研究所 | 单克隆抗体免疫比浊定量检测α-葡聚糖的试剂盒 |
JP2016105066A (ja) * | 2014-12-01 | 2016-06-09 | 三洋化成工業株式会社 | 磁性シリカ粒子、該磁性シリカ粒子を用いた測定対象物質測定方法及び測定対象物質測定用試薬 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107462721A (zh) * | 2017-07-10 | 2017-12-12 | 江苏福隆生物技术有限公司 | 细胞角蛋白19片段的板式化学发光法检测试剂盒及制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN106483298B (zh) | 2017-08-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103901203B (zh) | 一种降钙素原的化学发光定量检测试剂盒及其制备方法和检测方法 | |
CN105548565A (zh) | 一种用于检测克氏锥虫抗体的试剂盒及其制备和应用 | |
US20200309770A1 (en) | Chemiluminescence immunoassay kit for adiponectin, and preparation method and use thereof | |
Liu et al. | Magnetic-particle-based, ultrasensitive chemiluminescence enzyme immunoassay for free prostate-specific antigen | |
Yu et al. | Development of a clinical chemiluminescent immunoassay for serum GPC3 and simultaneous measurements alone with AFP and CK19 in diagnosis of hepatocellular carcinoma | |
CN105651990A (zh) | 一种17α-羟孕酮的化学发光检测试剂盒及其制备方法和应用 | |
JP6605627B2 (ja) | 免疫分析用の免疫抑制剤薬物の抽出試薬 | |
CN104634980A (zh) | 心肌肌钙蛋白i超敏检测试剂盒及超敏检测方法 | |
CN103353521B (zh) | 直读便携式血糖仪测定生物标志物及dna含量的方法 | |
CN103063851B (zh) | 一种游离三碘甲状腺原氨酸的纳米磁微粒化学发光测定试剂盒及其制备方法和检测方法 | |
CN102072957A (zh) | 丙型肝炎病毒抗体诊断试剂盒及其制备方法 | |
CN106443000B (zh) | 用于检测HBs抗原的样品的预处理方法及其利用 | |
CN104698184A (zh) | 检测糖类抗原的试剂盒及其检测方法和应用 | |
CN107389919A (zh) | 一种免标记荧光适配体传感器及其制备方法和应用 | |
CN108445230B (zh) | 基于纳米抗体的降钙素原化学发光检测试剂及检测方法 | |
CN101438163A (zh) | 利用磁场检测样品中的靶分子 | |
CN108139392A (zh) | Pivka-ii的测定方法及pivka-ii免疫测定试剂或试剂盒的制造方法 | |
CN108333346A (zh) | dsDNA免疫磁性微球体系、其制备方法和应用以及保存液 | |
CN104730257A (zh) | rT3化学发光免疫检测试剂盒及其检测方法和应用 | |
JPWO2010064435A1 (ja) | ヒト体液中のシスタチンc測定方法 | |
CN105181694B (zh) | 癌胚抗原胶乳增强免疫比浊试剂盒 | |
EP3243076B1 (en) | Methods for detecting a marker for active tuberculosis | |
Yang et al. | Clinic applications in assaying ultra-low-concentration bio-markers using HTS SQUID-based AC magnetosusceptometer | |
CN105849562B (zh) | 可溶性gpc3蛋白质的测定方法 | |
Gordon-Wylie et al. | Measuring protein biomarker concentrations using antibody tagged magnetic nanoparticles |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190212 Address after: 100096 Second Floor, Building A, No. 8 Zhongguancun Life Science Park Road, Huilongguan Town Science Park, Changping District, Beijing Patentee after: Juli Biotechnology (Beijing) Co.,Ltd. Address before: 510530 Guangzhou High-tech Industrial Development Zone, Guangdong Province Patentee before: GUANGZHOU HUAHONG BIOTECHNOLOGY CO.,LTD. |
|
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: Room 701, Unit 1, Building 8, No. 88 Kechuang 6th Street, Beijing Economic and Technological Development Zone, Daxing District, Beijing, 100176 Patentee after: Juli Biotechnology (Beijing) Co.,Ltd. Country or region after: China Address before: 100096 Second Floor, Building A, No. 8 Zhongguancun Life Science Park Road, Huilongguan Town Science Park, Changping District, Beijing Patentee before: Juli Biotechnology (Beijing) Co.,Ltd. Country or region before: China |